Real World Safety & Efficacy Experience of Empagliflozin With or Without Metformin in T2DM Patients - EASE Study

Recruiting

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(6 sites)

Afghanistan

Kabul University of Medical Sciences(KUMS), Kabul, Afghanistan

Kenya

Agha Khan univeristy hospital, Nairobi, Kenya

Nigeria

Lagos University Teaching Hospital, Lagos, Nigeria

Pakistan

Umar Diabetes Foundation, Islamabad

Sri Lanka

National hospital Sri Lanka, Colombo, Colombo

NHK, Kandy, Kandy